Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -358.6% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 31.4 | n/a |
Pr/Book | 30.4 |
Latest | F'cast | |
---|---|---|
Revenue | -50.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-21 | 1.60 | (2.91) | (3.92)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 4.04 | (2.64) | (3.24)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 1.75 | (8.30) | (11.35)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 0.86 | (3.14) | (0.71)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Notification of dealings by a director/PDMR | 09-Sep-2025 | 07:00 | RNS |
Therapeutic development agreement with Invizius | 02-Sep-2025 | 07:00 | RNS |
Block Listing Interim Review | 28-Aug-2025 | 07:00 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
08-Sep-25 | Buy | Adam Hargreaves | 1.00p | 5,000,000 | £50,000.00 |
24-Jul-25 | Placing | Timothy J Sykes | 0.34p | 2,968,695 | £9,998.56 |
18-Jul-25 | Placing | Timothy J Sykes | 0.34p | 2,968,695 | £9,998.56 |
Currency | UK Pounds |
Share Price | 0.98p |
Change Today | -0.025p |
% Change | -2.50 % |
52 Week High | 1.30 |
52 Week Low | 0.21 |
Volume | 1,021,633 |
Shares Issued | 2,696.98m |
Market Cap | £26.30m |
Beta | 0.10 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:59 | 12,131 @ 0.97p |
09:35 | 80,000 @ 0.97p |
09:32 | 142,077 @ 0.98p |
09:28 | 15,369 @ 0.98p |
09:22 | 27,642 @ 1.02p |
CEO | Arron Tolley |
CFO | Andrew Rapson |
You are here: research